These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30272002)

  • 1. Frequent mutation of the
    Annala M; Taavitsainen S; Vandekerkhove G; Bacon JVW; Beja K; Chi KN; Nykter M; Wyatt AW
    Commun Biol; 2018; 1():122. PubMed ID: 30272002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
    Parolia A; Cieslik M; Chu SC; Xiao L; Ouchi T; Zhang Y; Wang X; Vats P; Cao X; Pitchiaya S; Su F; Wang R; Feng FY; Wu YM; Lonigro RJ; Robinson DR; Chinnaiyan AM
    Nature; 2019 Jul; 571(7765):413-418. PubMed ID: 31243372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXA1 in prostate cancer.
    Dong HY; Ding L; Zhou TR; Yan T; Li J; Liang C
    Asian J Androl; 2023; 25(3):287-295. PubMed ID: 36018068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.
    Adams EJ; Karthaus WR; Hoover E; Liu D; Gruet A; Zhang Z; Cho H; DiLoreto R; Chhangawala S; Liu Y; Watson PA; Davicioni E; Sboner A; Barbieri CE; Bose R; Leslie CS; Sawyers CL
    Nature; 2019 Jul; 571(7765):408-412. PubMed ID: 31243370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
    Lehrer S; Rheinstein PH
    Discov Med; 2020; 30(161):163-171. PubMed ID: 33593484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional analysis of somatic coding and UTR indels in breast and lung cancer genomes.
    Chen J; Guo JT
    Sci Rep; 2021 Oct; 11(1):21178. PubMed ID: 34707120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXA1 mutations in hormone-dependent cancers.
    Robinson JL; Holmes KA; Carroll JS
    Front Oncol; 2013; 3():20. PubMed ID: 23420418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.
    Tsourlakis MC; Eleftheriadou A; Stender A; Weigand P; Grupp K; Hube-Magg C; Kluth M; Schroeder C; Steurer S; Hinsch A; Luebke A; Angerer A; Wittmer C; Friedrich E; Göbel C; Büscheck F; Heinzer H; Graefen M; Simon R; Sauter G; Wilczak W; Minner S; Schlomm T; Jacobsen F
    Carcinogenesis; 2017 Dec; 38(12):1180-1187. PubMed ID: 29029032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioneer of prostate cancer: past, present and the future of FOXA1.
    Teng M; Zhou S; Cai C; Lupien M; He HH
    Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.
    Felice D; Alaimo A; Bressan D; Genovesi S; Marmocchi E; Annesi N; Beccaceci G; Dalfovo D; Cutrupi F; Foletto V; Lorenzoni M; Gandolfi F; Kannan S; Verma CS; Vasciaveo A; Shen MM; Romanel A; Chiacchiera F; Cambuli F; Lunardi A
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
    Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
    Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important role of indels in somatic mutations of human cancer genes.
    Yang H; Zhong Y; Peng C; Chen JQ; Tian D
    BMC Med Genet; 2010 Sep; 11():128. PubMed ID: 20807447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
    Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
    Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
    Sun Q; Yu X; Degraff DJ; Matusik RJ
    Mol Endocrinol; 2009 Dec; 23(12):2038-47. PubMed ID: 19846536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Application of CRISPR/Cas9 Revealed Implication of
    Cai H; Agersnap SN; Sjøgren A; Simonsen MK; Blaavand MS; Jensen UV; Thomsen MK
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
    Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
    Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
    Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
    Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.
    Zhou S; Hawley JR; Soares F; Grillo G; Teng M; Madani Tonekaboni SA; Hua JT; Kron KJ; Mazrooei P; Ahmed M; Arlidge C; Yun HY; Livingstone J; Huang V; Yamaguchi TN; Espiritu SMG; Zhu Y; Severson TM; Murison A; Cameron S; Zwart W; van der Kwast T; Pugh TJ; Fraser M; Boutros PC; Bristow RG; He HH; Lupien M
    Nat Commun; 2020 Jan; 11(1):441. PubMed ID: 31974375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 20. Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity.
    Briney BS; Willis JR; Crowe JE
    Genes Immun; 2012 Oct; 13(7):523-9. PubMed ID: 22717702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.